Skip to content

The effectiveness of mindfulness intervention on improve medication adherence in patients with heart failure

The effectiveness of mindfulness intervention on improve medication adherence in patients with heart failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210314050700N1
Enrollment
120
Registered
2021-04-28
Start date
2021-04-21
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Mindfulness intervention. Condition 2: Heart failure. Condition 3: Medication adherence. Heart failure

Interventions

Intervention 1: Intervention group: it is includes 50 individuals of the patients heart failure whom will participate in mindfulness sessions.the eight- week training intervention will include: raisin

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 70 Years

Inclusion criteria

Inclusion criteria: Informed consent and voluntary participation in the study Have a heart failure diagnosed by cardiologist No mental disorders or addiction Level of education No more than 70 years old Having digital literacy and familiarity with social networks

Exclusion criteria

Exclusion criteria: Reluctance to participate in the study Severe psychological or physical consequences Drug addiction History of attending or participating in a mindfulness training program related to medication adherence Patient who is responsible for the timely use of his drugs Taking drugs that somehow affect the patient's consciousness Lack of literacy

Design outcomes

Primary

MeasureTime frame
Assessing the behavior of medication adherence. Timepoint: At the beginning of the study and one month and three months after the educational intervention. Method of measurement: Medication Adherence Rating Scale.;Self-efficacy. Timepoint: At the beginning of the study and one month and three months after the educational intervention. Method of measurement: Health Action Process Approach Questionnaire.;Assessing the perceived risk of non-adherence medication. Timepoint: At the beginning of the study and one month and three months after the educational intervention. Method of measurement: Health Action Process Approach Questionnaire.;Assessing planned behavior. Timepoint: At the beginning of the study and one month and three months after the educational intervention. Method of measurement: Health Action Process Approach Questionnaire.;Behavioral intention. Timepoint: At the beginning of the study and one month and three months after the educational intervention. Method of measurement: Health Action Process Approach Questionnaire.

Secondary

MeasureTime frame
Outcome expectations. Timepoint: At the beginning of the study and one month and three months after the educational intervention. Method of measurement: Health Action Process Approach Questionnaire.;Quality of life. Timepoint: At the beginning of the study and one month and three months after the educational intervention. Method of measurement: Minnesota Living with Heart Failure Questionnaire.;Severe insomnia. Timepoint: At the beginning of the study and one month and three months after the educational intervention. Method of measurement: Insomnia severity index Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohre Ebadian

Qazvin University of Medical Sciences

info@qums.ac.ir+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026